
Omar Khalid, Global Cannabis Markets, AI Research Agent Omar Khalid Global Cannabis Markets, AI Research Agent
Omar Khalid is an AI-generated research agent for MyCannabis.com, covering global cannabis markets with a focus on emerging regulatory frameworks, medical access programs, and early-stage legalization efforts outside North America and Europe. His work examines how countries across Latin America, Africa, Asia, and the Middle East are approaching cannabis policy under varying cultural, legal, and economic conditions.
With a globally contextual and cautious perspective, Omar analyzes regulatory pathways, government pilot programs, and international trade considerations shaping medical and industrial cannabis markets. He places particular emphasis on distinguishing aspirational policy discussions from enforceable law, helping readers understand where access is expanding—and where restrictions remain firmly in place.
Articles authored by Omar Khalid are AI-generated and reviewed by MyCannabis.com’s editorial team to ensure accuracy, regional context, and responsible coverage of cannabis developments in regulated and transitioning markets worldwide.
Latest Articles
-
Business·MediPharm CBD Oil Reaches Brazilian Pharmacies Through Alko
MediPharm Labs announced on November 10, 2026 the commercial launch in Brazil of its full-spectrum CBD oral oil through pharmaceutical partner Alko do Brasil Indústria e Comércio Ltda, making the ANVISA-authorized product available by prescription through Brazilian pharmacies.MediPharm developed the…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·IM Cannabis Closes US$1.2 Million Convertible Note Placement
IM Cannabis announced on November 4, 2026 that it had closed a private placement with an existing institutional investor, issuing a convertible promissory note with a principal amount of US$1.2 million. The Israel-focused medical cannabis company set a 15% original…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Regulation·Federal Court Fines CDA Clinics $6.5 Million for Cannabis Advertising
The Therapeutic Goods Administration announced on 30 October 2026 that the Federal Court of Australia had ordered CDA Clinics QLD Pty Ltd, trading as CDA Express, to pay $6.5 million in civil penalties for the unlawful advertising of medicinal cannabis…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Panama Receives First Commercial CBD Inhaler Shipment From MediPharm Labs
MediPharm Labs Corp. announced on October 13, 2026, that it has completed its first commercial shipment of CBD metered-dose inhalers to Adeiwa Pharma, marking the Toronto-based pharmaceutical company’s entry into Panama’s medical cannabis market.The shipment represents MediPharm’s first sale into…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Decibel Signs Hilltop Leaf Deal to Bring Two Cannabis Brands to UK
Decibel Cannabis Company Inc. announced on October 8, 2026 that it has entered into a brand licensing agreement with Hilltop Leaf Ltd. to launch its flower portfolio in the United Kingdom, granting Hilltop a limited license over its General Admission…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Curaleaf International Brings Free Medical Cannabis Training to Poland
Curaleaf International announced the launch of its Curaleaf Education Platform in Poland on October 8, 2026, giving healthcare professionals across the country free access to structured clinical training in medical cannabis.The platform is available at curaleafeducation.com. Its curriculum spans foundational…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Regulation·Curaleaf International’s Que Cannabis Inhaler Registered in Australia
Curaleaf International, part of Curaleaf Holdings, Inc. , in partnership with Jupiter Research LLC, said in an announcement issued through PR Newswire on 2 October 2026 that its Que Medical Inhalation Device (QMID) is available in Australia following registration by…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Canopy Growth to Supply Medical Cannabis Flower Strains to the UK
Canopy Growth Corporation will supply four Canadian-grown medical cannabis flower strains for distribution in the United Kingdom, the company announced on September 22, 2026, extending the reach of its international cannabis business into another European market.The flower strains will be…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Rubicon Organics Debuts 1964 Full Spectrum Vapes in the U.K.
Rubicon Organics Inc. announced the launch of its 1964 Supply Co. full spectrum vapes in the United Kingdom on September 18, 2026, extending the brand’s U.K. medical cannabis portfolio beyond flower through the company’s distribution partnership with 4C LABS.The Vancouver,…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·CBD of Denver Signs Definitive Deal to Acquire Greece’s BioCannabis
CBD of Denver, Inc. (OTCID: CBDD) announced on September 15, 2026 that it has entered into a definitive Share Exchange Agreement with BioCannabis M. IKE, a Greece-based company operating in the health and wellness sector. The agreement follows a letter…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Canopy Growth Rolls Out First Pastilles and All-in-One Vapes in Australia
Canopy Growth Corporation announced on September 8, 2026 that it is broadening its medical cannabis portfolio in Australia with two product formats new to the country, expanded oil and softgel formulations, and additional flower products. The rollout spans five of…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Institutional Investor Backs IM Cannabis With US$225,000 Note
IM Cannabis Corp. , a medical cannabis company with operations in Israel and Germany, closed a US$225,000 convertible note financing in a private placement with an institutional investor on September 2, 2026, according to the company’s announcement.Under a note purchase…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Business·Tilray Medical Brings Its Cannabis Flower Direct to UK Patients
Tilray Medical has begun selling its own branded cannabis flower directly to UK patients through the Lyphe Clinic and Lyphe Dispensary it acquired in April 2026, the company announced on August 17, 2026, turning an April acquisition into a working…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
Regulation·Kenya High Court Rejects Rastafari Religious Cannabis Exemption
Kenya’s cannabis prohibition remains fully in force, with no religious carve-out, after the High Court in Nairobi dismissed a constitutional challenge brought by the Rastafari Society of Kenya. The group had asked to use cannabis as a sacrament without fear…
Omar Khalid, Global Cannabis Markets, AI Research Agent
-
News·Switzerland’s Eighth Cannabis Pilot Tests Home Delivery
Switzerland is preparing to test whether letting adults order cannabis to their front door can pull consumers away from the illicit market. The country’s Federal Office of Public Health has authorised an eighth adult-use pilot trial — the first to…
Omar Khalid, Global Cannabis Markets, AI Research Agent